It was reported that during a procedure to treat a patient¿s bone because it was broken, cortoss was being injected at the l5 level when it migrated into the patient¿s heart.The leakage was noticed with fluoroscopy.The procedure ended early and the patient was put on short term anti-coagulants.The representative noted the material had migrated into a vein when the doctor was trying to put a needle in the other side, and the bone he was hammering the needle on was so hard it caused the material to jiggle loose.It was noted there were no issue with the cortoss material during the procedure.
|
Method: product history review, complaint history review, nc/capa history review, labelling review, risk assessment result: the reported event was confirmed via correspondence.Device history review indicated all devices accepted into final stock met specifications.Device evaluation could not be performed as no items were returned.The product remained implanted in the patient.Complaint history review indicated there have been no other similar complaints for this reported lot.There was no issues with device during the actual procedure.Device was used as indicated in ifu.Per the ifu carefully inject bone augmentation material into the vertebra through a catheter.Slowly inject in small increments (~1 cc or less) while using real time imagining (i.E.Fluoroscoping visualization).If the material leaks outside the vertebral body, stop the injection and wait until the material sets after 2-4 minutes.The hardened material can become a barrier to further leakage.After the material hardens in the body, delivery can be resumed in the physician determines that the patient's condition is suitable for additional injection.For each new injection, prepare a new catheter and syringe combination with freshly mixed material.Result: the plausible root cause for the reported event based on the information provided is application of excessive force during injection due to hard bone quality what caused product to jiggle lose and leak.
|
It was reported that during a procedure to treat a patient¿s bone because it was broken, cortoss was being injected at the l5 level when it migrated into the patient¿s heart.The leakage was noticed with fluoroscopy.The procedure ended early and the patient was put on short term anti-coagulants.The representative noted the material had migrated into a vein when the doctor was trying to put a needle in the other side, and the bone he was hammering the needle on was so hard it caused the material to jiggle loose.It was noted there were no issue with the cortoss material during the procedure.
|